- Clinical Interests
- Hepatitis C virus (HCV)
- AIDS and HIV infection
- Infectious diseases
- Medical Education
- MD, Case Western Reserve University School of Medicine
- Residency, Massachusetts General Hospital
- Board Certifications
- Internal Medicine
- Infectious Disease
- Foreign Languages
- Boston: Massachusetts General Hospital
- Insurances Accepted
- Aetna Health Inc.
- Beech Street
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- Cigna (PAL #'s)
- Fallon Community HealthCare
- Great-West Healthcare (formally One Health Plan)
- Harvard Pilgrim Health Plan - ACD
- Harvard Pilgrim Health Plan - PBO
- Health Care Value Management (HCVM)
- Humana/Choice Care PPO
- Medicare - ACD
- Neighborhood Health Plan - ACD
- Neighborhood Health Plan - PBO
- OSW - Connecticut
- OSW - Maine
- OSW - New Hampshire
- Private Health Care Systems (PHCS)
- Railroad Medicare
- Railroad Medicare - ACD
- Senior Whole Health
- Tufts Health Plan
- United Healthcare (non-HMO) - ACD
- United Healthcare (non-HMO) - PBO
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
- Patient Age Group
Investigators from the Ragon Institute of MGH, MIT and Harvard and the Broad Institute of MIT and Harvard have used the revolutionary new gene-editing technology CRISPR-Cas9 to identify three promising new targets for treatment of HIV infection.
The MGH has received a top honor from the Massachusetts Department of Public Health (DPH) for its commitment to improving its quality of care to stroke patients.
The rare ability of some individuals to control HIV infection with their immune system alone appears to depend &ndash; at least partially &ndash; on specific qualities of the immune system's killer T cells and not on how many of those cells are produced.
In a new finding that may allow vaccine designers to sidestep HIV's rapid mutation rate, researchers at the Ragon Institute of MGH, MIT and Harvard have identified sections of an HIV protein where mutations would actually undermine the virus&rsquo; fitness &ndash; its ability to survive and reproduce.
Tiny variants in a protein that alerts the immune system to the presence of infection may underlie the rare ability of some individuals to control HIV infection without the need for medications.
Researchers from the Ragon Institute of MGH, MIT and Harvard discover how a genetic factor increases the immune system's ability to control HIV.
MGH Hotline 04.23.10 Bruce Walker, MD, director of the Ragon Institute of MGH, MIT and Harvard, is among 229 individuals who have been selected to join the American Academy of Arts and Sciences (AAAS) this year.
MGH Hotline 10.16.09 Seven MGH-affiliated physicians and researchers join prestigious Institute of Medicine seven MGH-affiliated physicians and researchers were among the 65 new members and five foreign associates recently elected to the prestigious Institute of Medicine (IOM), a recognized leader for independent, scientifically informed analysis and recommendations on health issues.
The National Institutes of Health has renewed for five years - and $18.1 million - the funding for the Harvard University Center for AIDS Research (Harvard CFAR). Harvard is one of only 20 NIH CFAR sites in the U.S. and first received the designation in 2004.
A groundbreaking partnership between the Howard Hughes Medical Institute and the University of KwaZulu-Natal in South Africa will establish an international research center focused on the worldwide effort to control the devastating co-epidemic of tuberculosis and HIV.
HIV is evolving rapidly to escape the human immune system, an international study has shown. The findings demonstrate the challenge of developing an HIV vaccine that keeps pace with the changing nature of the virus.
Turning Science Into Medicine
Mass General has the largest hospital-based research program in the United States. Explore some of our current research projects and recent milestones in cancer, AIDS, genetics, transplantation, schizophrenia and basic research.
55 Fruit Street
Boston, MA 02114-2696
Phone 1: 857-268-7072
Phone 2: 617-726-3812